Quantitative methods for estimation of cancer risk have been developed for daily, lifetime human exposures.
A Proposed Framework for Assessing Risk From Less-Than-Lifetime Exposures to Carcinogens
Critical Reviews in Toxicology, 2011
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Critical Reviews in Toxicology, 2011
Quantitative methods for estimation of cancer risk have been developed for daily, lifetime human exposures.
Environmental and Molecular Mutagenesis, 2011
To view the full citation, click here.
Toxicological Sciences, 2011
This study reports the evaluation of four urinary biomarkers of renal toxicity, α-glutathione-S-transferase (α-GST), μ-GST, clusterin, and renal papillary antigen-1 (RPA-1), in male Sprague-Dawley and Han-Wistar rats given cisplatin, gentamicin, or N-phenylanthranilic acid (NPAA).
Toxicological Sciences, 2011
Thalidomide was a widely used drug in the late 1950s and early 1960s for the treatment of nausea in pregnant women.
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2011
The ILSI Health and Environmental Sciences Institute's Developmental and Reproductive Toxicology Technical Committee held a 2-day workshop entitled “Developmental Toxicology—New Directions” in April 2009.
Journal of Immunotoxicology, 2011
The Immunotoxicology Technical Committee of HESI sponsored a retrospective analysis of T-cell-dependent antibody responses in non-human primates (NHP).
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.